This article has been updated from a previous version to update the availability and shipping timelines for Illumina's new sequencers.
SAN FRANCISCO (GenomeWeb) – Illumina President and CEO Francis deSouza on Monday unveiled the company's two newest sequencing platforms, the NextSeq 1000 and NextSeq 2000, at the JP Morgan Healthcare Conference held here.
In addition, deSouza said that Illumina achieved preliminary year-over-year revenue growth of 10 percent in the fourth quarter and 6 percent for full-year 2019.